The Rapidly Evolving Landscape of Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Endometrial Carcinoma and Other Gynecologic Malignancies
The clinical indications and demand for HER2 testing in gynecologic malignancies beyond endometrial cancer are expanding. It is essential for practicing pathologists to stay up to date on the latest clinical developments and use evidence-based HER2 testing and scoring criteria.
Authors
- Natália Buza (ORCID: https://orcid.org/0000-0002-0008-334X)
Institutions
- Yale University (US)
Publication Details
- Journal
- Archives of Pathology & Laboratory Medicine
- Published
- 2025-06-02
- DOI
- https://doi.org/10.5858/arpa.2025-0046-ra
- Citations
- 3
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 3.14